These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1301 related items for PubMed ID: 28920172

  • 1. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
    Worland T, Harrison B, Delmenico L, Dowling D.
    J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
    [Abstract] [Full Text] [Related]

  • 2. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
    Ungtrakul T, Mahidol C, Chun-On P, Laohapand C, Siripongsakun S, Worakitsitisatorn A, Vidhayakorn S, Boonchuay W, Dechma J, Sornsamdang G, Soonklang K, Sriprayoon T, Tanwandee T, Auewarakul CU.
    World J Gastroenterol; 2016 Sep 14; 22(34):7806-12. PubMed ID: 27678364
    [Abstract] [Full Text] [Related]

  • 3. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Chang TS, Wu YC, Tung SY, Wei KL, Hsieh YY, Huang HC, Chen WM, Shen CH, Lu CH, Wu CS, Tsai YH, Huang YH.
    Am J Gastroenterol; 2015 Jun 14; 110(6):836-44; quiz 845. PubMed ID: 25869392
    [Abstract] [Full Text] [Related]

  • 4. Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis.
    Kim MN, Kim BK, Kim SU, Park JY, Ahn SH, Han KH, Kim DY.
    Scand J Gastroenterol; 2019 Oct 14; 54(10):1283-1290. PubMed ID: 31593481
    [Abstract] [Full Text] [Related]

  • 5. No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis.
    Moon AM, Weiss NS, Beste LA, Su F, Ho SB, Jin GY, Lowy E, Berry K, Ioannou GN.
    Gastroenterology; 2018 Oct 14; 155(4):1128-1139.e6. PubMed ID: 29981779
    [Abstract] [Full Text] [Related]

  • 6. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
    Tzartzeva K, Obi J, Rich NE, Parikh ND, Marrero JA, Yopp A, Waljee AK, Singal AG.
    Gastroenterology; 2018 May 14; 154(6):1706-1718.e1. PubMed ID: 29425931
    [Abstract] [Full Text] [Related]

  • 7. Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis.
    Tayob N, Christie I, Richardson P, Feng Z, White DL, Davila J, Corley DA, Kanwal F, El-Serag HB.
    Clin Gastroenterol Hepatol; 2019 Aug 14; 17(9):1886-1893.e5. PubMed ID: 30557738
    [Abstract] [Full Text] [Related]

  • 8. Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase.
    Yang JD, Dai J, Singal AG, Gopal P, Addissie BD, Nguyen MH, Befeler AS, Reddy KR, Schwartz M, Harnois DM, Yamada H, Gores GJ, Feng Z, Marrero JA, Roberts LR.
    Cancer Epidemiol Biomarkers Prev; 2017 Jul 14; 26(7):1085-1092. PubMed ID: 28258053
    [Abstract] [Full Text] [Related]

  • 9. Validity of alpha fetoprotein for diagnosis of hepatocellular carcinoma in cirrhosis.
    Sarwar S, Khan AA, Tarique S.
    J Coll Physicians Surg Pak; 2014 Jan 14; 24(1):18-22. PubMed ID: 24411536
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, Carroccio A, Sesti R, Tripi S, Montalto G.
    Anticancer Res; 2003 Jan 14; 23(2C):1747-53. PubMed ID: 12820452
    [Abstract] [Full Text] [Related]

  • 11. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
    Thompson Coon J, Rogers G, Hewson P, Wright D, Anderson R, Cramp M, Jackson S, Ryder S, Price A, Stein K.
    Health Technol Assess; 2007 Sep 14; 11(34):1-206. PubMed ID: 17767898
    [Abstract] [Full Text] [Related]

  • 12. Liver Stiffness and Serum Alpha-Fetoprotein in Discriminating Small Hepatocellular Carcinoma from Cirrhotic Nodule.
    Li JW, Ling WW, Lu Q, Lu CL, He D, Luo Y.
    Ultrasound Q; 2016 Dec 14; 32(4):319-326. PubMed ID: 27575844
    [Abstract] [Full Text] [Related]

  • 13. Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm.
    Tayob N, Lok AS, Do KA, Feng Z.
    Clin Gastroenterol Hepatol; 2016 Mar 14; 14(3):469-475.e2. PubMed ID: 26260109
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis.
    Singal AG, Conjeevaram HS, Volk ML, Fu S, Fontana RJ, Askari F, Su GL, Lok AS, Marrero JA.
    Cancer Epidemiol Biomarkers Prev; 2012 May 14; 21(5):793-9. PubMed ID: 22374994
    [Abstract] [Full Text] [Related]

  • 15. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis.
    Arguedas MR, Chen VK, Eloubeidi MA, Fallon MB.
    Am J Gastroenterol; 2003 Mar 14; 98(3):679-90. PubMed ID: 12650806
    [Abstract] [Full Text] [Related]

  • 16. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X, Chi X, Gong Q, Gao L, Niu Y, Chi X, Cheng M, Si Y, Wang M, Zhong J, Niu J, Yang W.
    PLoS One; 2015 Mar 14; 10(5):e0127518. PubMed ID: 25996938
    [Abstract] [Full Text] [Related]

  • 17. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.
    Paul SB, Gulati MS, Sreenivas V, Madan K, Gupta AK, Mukhopadhyay S, Acharya SK.
    Oncology; 2007 Mar 14; 72 Suppl 1():117-23. PubMed ID: 18087192
    [Abstract] [Full Text] [Related]

  • 18. Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma.
    Ricco G, Cosma C, Bedogni G, Biasiolo A, Guarino M, Pontisso P, Morisco F, Oliveri F, Cavallone D, Bonino F, Plebani M, Brunetto MR.
    Cancer Biomark; 2020 Mar 14; 29(2):189-196. PubMed ID: 32623383
    [Abstract] [Full Text] [Related]

  • 19. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct 14; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 20. Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System.
    Tayob N, Richardson P, White DL, Yu X, Davila JA, Kanwal F, Feng Z, El-Serag HB.
    BMC Med Res Methodol; 2018 Jan 04; 18(1):1. PubMed ID: 29301497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.